Form 8-K - Current report:
SEC Accession No. 0000950170-24-135204
Filing Date
2024-12-11
Accepted
2024-12-11 06:30:07
Documents
15
Period of Report
2024-12-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K itrm-20241210.htm   iXBRL 8-K 45524
2 EX-5.1 itrm-ex5_1.htm EX-5.1 52319
3 GRAPHIC img64471200_0.jpg GRAPHIC 50301
4 GRAPHIC img64471200_1.jpg GRAPHIC 50301
5 GRAPHIC img64471200_2.jpg GRAPHIC 13126
  Complete submission text file 0000950170-24-135204.txt   382341

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT itrm-20241210.xsd EX-101.SCH 26763
17 EXTRACTED XBRL INSTANCE DOCUMENT itrm-20241210_htm.xml XML 4891
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 241540098
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)